Environmental and Experimental Factors Affecting Efficacy Testing of Nonporous Plastic Antimicrobial Surfaces

Test methods for efficacy assessment of antimicrobial coatings are not modelled on a hospital environment, and instead use high humidity (>90%) high temperature (37 °C), and no airflow. Therefore, an inoculum will not dry, resulting in an antimicrobial surface exhibiting prolonged antimicrobial activity, as moisture is critical to activity. Liquids will dry quicker in a hospital ward, resulting in a reduced antimicrobial efficacy compared to

Welcome Bosnia and Herzegovina became new partner countries in the AMiCI COST Action

Following the E-vote on the approval of Bosnia and Herzegovina as a partner country in the AMiCI Action, thise countries became new partner countries in the AMiCI COST Action. Proposal has been accepted by 18 countries voting Yes and other 13 countries abstaining, which – according to the COST rules – is equal to the positive vote. The outcome of this vote will be recorded

AMiCI on 10th Congress of Toxicology in Developing Countries (Belgrade, Serbia)

The Symposium “Antimicrobial coatings in healthcare settings: efficiency versus safety” Infections and infectious diseases are considered a major challenge to human health in healthcare units worldwide. As antimicrobial materials (such as silver and copper) are inherently toxic, the application of (nano-enabled) antimicrobial surface coatings (AMCs) in healthcare settings may cause harm in addition to benefits. Indeed, in parallel to cutting down the spread of potentially

The AMiCI COST Action on 2017 ECSJ in Copenhagen

The AMiCI Action has been selected, as one of 10 COST Actions, to be presented on this year’s European Conference for Science Journalists (Copenhagen, 26-30 June), the largest gathering of science journalists in Europe in 2017. This is a great chance to communicate about the issue and how important collaborative science is in the society. Antimicrobial Coatings as Weapon Against Infectious Diseases HealthCare Associated Infections (HAI) are

COST multidisciplinary European research networks are key to FP9

On 15 June, the COST Committee of Senior Officials (CSO) published its position paper, highlighting the importance of multidisciplinary, bottom-up, open and inclusive networks, pleading for sufficient funding post Horizon 2020. Investment in research and innovation is key for the EU to realise its ambition of becoming a smart, sustainable and inclusive economy and to contribute to the well-being of society. Therefore, EU policy makers

Pori Ready to Welcome Participants of AMiCI meeting (June 6-8th)

Pori is ready to welcome participants of the second COST Action AMiCI conference. The final program of the meeting: Day 1 (6th of June) The Conference ‘Antimicrobial coatings in healthcare: from innovation to the market’. Key-note speakers will cover issues along the AMC value chain; from patents, regulatory, implementation in hospitals, to evaluation of the impact taken from a real life example. The conference will

PhD student positions available in the Marie-Sklodowska- Curie European Training Network “PRINT-AID”

Applications are invited for 9 PhD student positions available in the Marie-Sklodowska-Curie European Training Network: “PRINT-AID – Multidisciplinary European training network for development of personalized anti-infective medical devices combining printing technologies and antimicrobial functionality” within the Horizon 2020 Programme of the European Commission. PRINT-AID aims to provide high-quality research training to Early Stage Researchers. By bringing together experts in antimicrobial drug development, microbial biofilms, 3D-printing technologies, in vivo preclinical infection

Anti-microbial coating innovations to prevent healthcare-associated infection

Commentary: Worldwide, millions of patients are affected annually by healthcare-associated infection (HCAI), impacting up to 80,000 patients in European Hospitals on any given day.[1] This represents not only public health risk, but also an economic burden. Through its Cooperation in Science and Technology programme (COST), the European Commission has recently funded a four-year initiative to establish a network of stakeholders involved in development, regulation and use of novel anti-microbial coatings for

Twenty-nine countries join forces to prevent healthcare associated infectious diseases

Over sixty universities, research institutes and companies from twenty-nine European countries will jointly study the impact of applying antimicrobial (nano-)coatings on decreasing the spread of infections. The beneficial aspects of these measures will be assessed in the context of potential environmental adverse effects, as well as development of bacterial resistance. It is the first time that this pressing issue is addressed on such a scale.

Welcome at the AMiCI website!

AMiCI is the acronym of AntiMicrobial Coating Innovations. It is a consortium which was initiated by researchers at the Zuyd University of Applied Sciences in the Netherlands in 2012. AMiCI brings together stakeholders from different countries and disciplines, including knowledge institutes, producers and processors of antimicrobial coatings, and organizations involved in the compliance with international standards on hygiene. The central aim is to evaluate the